Therapeutic substitution could reduce US drug spending by nearly 10%, study finds

The routine use of therapeutic substitution—where cheaper, chemically different compounds from the same therapeutic drug class are substituted for higher priced brand name drugs—could reduce US drug spending by nearly 10%, a new study in JAMA Internal Medicine has found.1